Physician profile
Jeff E Schulman
NPI 1912121898
$34,852.32
in general payments reported to CMS, 2019-2025
12 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $255 · 2021: $6,872 · 2022: $5,291 · 2023: $480 · 2024: $5,948 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,351 · Food and Beverage: $2,400 · Consulting Fee: $1,225 · Honoraria: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,350.56 |
| Food and Beverage | $2,400.25 |
| Consulting Fee | $1,225.00 |
| Honoraria | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20,974.62 | 2019-2025 | Gamma, Axsos, Variax |
| Medical Device Business Services, INC. | $8,576.45 | 2019-2021 | |
| Si-Bone, INC. | $2,755.07 | 2024 | |
| Depuy Synthes Sales INC. | $1,052.73 | 2019-2025 | Na, Va-Lcp, Tfn-Advance |
| Curvafix, INC. | $750.00 | 2025 | Curvafix Im Implant |
| Innovation Technologies INC | $336.54 | 2020-2023 | Irrisept |
| Zimmer Biomet Holdings, INC. | $187.53 | 2019 | |
| Neos Therapeutics, LP | $83.43 | 2019 | |
| Kerecis Limited | $47.72 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Corium, LLC | $46.87 | 2023 | Azstarys |
| Bone Support INC. | $25.96 | 2024 | Ceramentbone Void Filler, Cerament G |
| Smith+Nephew, INC. | $15.40 | 2024 | Evos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Schulman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.